CHD5 and neoplasm: CHD5 is believed to serve as a master regulator in tumor-suppressive networks, and CHD5 expression levels are strongly associated with the prognosis of several cancers, including hepatocellular carcinoma and non-small cell lung cancer [20, 22–24].